drugset / Trial / NCT01254396

Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.

NCT01254396

Phase 1 Completed 12 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This study will evaluate if an orally disintegrating tablet of sildenafil will have similar pharmacokinetic properties when given with food and without food.

Timeline

Start
2010-12
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg Oral

Indications